Neoadjuvant tislelizumab and tegafur/gimeracil/octeracil (s-1) plus oxaliplatin in patients with locally advanced gastric or gastroesophageal junction cancer: early results of a phase 2, single-arm trial
HIGHLIGHTS who: Yuping Yin from the China Qingdao University, China have published the Article: Neoadjuvant tislelizumab and tegafur/gimeracil/octeracil (S-1) plus […]